DPP4 and type 2 diabetes mellitus: In the future, more prospective studies should be carried out to observe liver-specific endpoints after the use of DPP-4 inhibitors or different antiglycemic agents in combination with DPP-4 inhibitors in T2DM patients with hepatitis virus infection.